Ocular Therapeutix, Inc.

OCUL XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

1.9B

Short interest (Jul 15)

12.3%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.41%

↑ 22.0%

Available Shares

↑ 61.5%

Price Chart

Company Overview

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001393434

Asset Type: CS

Market Data

Market Cap: $1,862,257,844

Employees: 325

Status: Active

Short Interest

Current Borrow Fee 0.41%

Range: 0.41% - 0.41%

Available Shares 2M

Range: 1.2M - 2.1M

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 23.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime